10.63  -0.01 (-0.09%)		06-29 16:00
Open: 10.63 High: 10.64 Volume: 28,488		Pre. Close: 10.64 Low: 10.63 Market Cap: 358(M)

Short term
Mid term
Targets	6-month :	12.43	1-year :	14.52
Resists	First :	10.64	Second :	12.43
Pivot price	10.62
Supports	First :	10.61	Second :	10.59
MAs	MA(5) :	10.63	MA(20) :	10.61
	MA(100) :	10.53	MA(250) :	10.39
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	88.8	D(3) :	96.2
RSI	RSI(14): 61
52-week	High :	10.64	Low :	10.17

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ DMAA ] has closed below upper band by 38.2%. Bollinger Bands are 7.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	10.66 - 10.72	10.72 - 10.77
Low:	10.47 - 10.55	10.55 - 10.61
Close:	10.52 - 10.64	10.64 - 10.73

Drugs Made In America Acquisition Corp. functions as a special purpose acquisition company, commonly known as a blank check company. Its core mission is to seek out and ultimately acquire one or more existing businesses or their assets. This acquisition strategy encompasses a variety of transactional methods, such as corporate mergers, capital stock exchanges, direct asset purchases, stock acquisitions, or broader corporate reorganizations.

Fri, 26 Jun 2026
Feis Equities and Lawrence Feis disclose 5.08% ownership in DMAA (DMAA) - Stock Titan

Wed, 08 Apr 2026
Drugs Made in America Acquisition Corp. signs LOI for de-SPAC with Power Analytics - Investing.com

Mon, 17 Nov 2025
DMAA SEC Filings - Drugs Made In Amer Acqutn Corp 10-K, 10-Q, 8-K Forms - Stock Titan

Sat, 16 Aug 2025
Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) is definitely on the radar of institutional investors who own 38% of the company - Yahoo Finance

Thu, 20 Mar 2025
Bright Green Exits Cannabis Business - CRB Monitor News

Wed, 19 Feb 2025
Drugs Made In America Acquisition Corp. Announces Closing of Full Exercise of IPO Over-Allotment Option - The Manila Times

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Financial Services
Industry: Shell Companies
Shares Out	24 (M)
Shares Float	29 (M)
Held by Insiders	18.4 (%)
Held by Institutions	98.2 (%)
Shares Short	77 (K)
Shares Short P.Month	97 (K)

EPS	0.2
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-0.22
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	18.7 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	53.15
PEG Ratio	0
Price to Book value	-48.32
Price to Sales	0
Price to Cash Flow	-680.66

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.